GLP-1 Medications Highlight Nutritional Needs in Diabetes Treatment

A major shift in diabetes and obesity management is evident as GLP-1 medications gain traction among American patients. While these drugs significantly affect calorie intake, their introduction requires careful attention to nutritional adjustments to ensure patient health.

Want to explore the research behind this topic?Search the NPRL

Rising Use of GLP-1 Medications

The adoption of GLP-1 medications has surged, with a 2025 KFF poll indicating that 12% of U.S. adults reported current usage and 18% had used them at some point. These medications mimic a hormone that regulates blood sugar, which can curb appetite and enhance feelings of fullness. While they effectively reduce daily calorie intake by 16% to 39%, this change necessitates a more focused approach to nutrition for those undergoing treatment.

GLP-1 medications effectively reduce daily calorie intake by 16% to 39%; this change necessitates a more focused approach to nutrition for those undergoing treatment.

Patients’ Nutritional Shortcomings

A recent preliminary study published in the Journal of Translational Medicine in 2026 analyzed dietary intake among 387 adults receiving GLP-1 or dual GIP-GLP-1 medications. The findings revealed an average daily caloric intake of just 753 calories, comprising only 33.4 grams of protein and 7.2 grams of fiber. Alarmingly, fewer than 10% of these participants met the recommended intake levels for key nutrients such as protein, fiber, vitamin D, calcium, and potassium. This disconnect highlights a significant challenge in patient dietary adaptation, suggesting that lower calorie consumption does not inherently equate to adequate nutrition.

The Need for Integrated Nutritional Support

Further investigation into the side effects of GLP-1 medications, as discussed in a 2025 review published in the International Journal of Obesity, identified gastrointestinal issues like nausea, vomiting, diarrhea, and constipation as prevalent among users. These complications underscore the vital need for ongoing nutritional assessment and support throughout treatment. Jena Salisbury, a clinical nutritionist and founder of Innate Clinical Nutrition, emphasizes that effective nutritional guidance must be integrated into the treatment pathway. She argues that without structured support, patients may struggle to meet their evolving nutritional needs as their dietary patterns change.

THE CNP TAKEAWAY

As GLP-1 medications become more common in diabetes treatment, it is crucial that healthcare providers prioritize nutritional support for patients. Customized nutritional frameworks can enhance patient care and improve overall health outcomes during treatment.